Leading brokers name 3 ASX shares to buy today

Here’s why brokers rate these ASX shares as buys…

| More on:
ASX shares Business man marking buy on board and underlining it

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares leading brokers have named as buys this week are listed below. Here’s why they are bullish on them:

Appen Ltd (ASX: APX)

According to a note out of Citi, its analysts have retained their buy rating and $9.15 price target on this artificial intelligence data services company’s shares. This follows an update out of Meta (Facebook), which revealed an increase in artificial intelligence and machine learning investment. Citi feels this bodes well for Appen given how Facebook is one of the company’s biggest customers. The Appen share price is trading at $6.39 on Monday afternoon.

Coles Group Ltd (ASX: COL)

A note out of Morgans reveals that its analysts have retained their add rating and lifted their price target on this supermarket giant’s shares to $20.65. Morgans highlights that Coles delivered a third quarter sales update slightly ahead of its estimates. It feels this was a big positive given the major disruptions during the period. Overall, the broker continues to see Coles as a good value option with defensive qualities and the capacity to invest in growth opportunities. The Coles share price is fetching $18.52 today.

ResMed Inc (ASX: RMD)

Analysts at Goldman Sachs have retained their buy rating but trimmed their price target on this sleep treatment company’s shares to $33.70. Goldman notes that ResMed’s quarterly update highlighted that supply chain pressures remain acute and the near-term upside from the key competitor recall remains more limited than hoped. Nevertheless, the broker believes ResMed is still in a stronger position today than 12 months ago and does not believe the near term challenges should be overcapitalised. The ResMed share price is trading at $28.63 on Monday.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Appen Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended COLESGROUP DEF SET. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Why analysts say investors should buy these top ASX shares

Analysts are saying that these shares are in the buy zone…

Read more »

best asx shares represented by best in show ribbon
Broker Notes

3 more of Morgans’ best ASX share ideas for July

These three ASX shares are highly rated...

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers rate these ASX shares as buys...

Read more »

A female construction project manager in a hi vis vest and hard hat considers progress on a chart on the wall.
Broker Notes

Down 10% in a month, could Boral shares be a buy?

Some are still constructive on the construction player's shares.

Read more »

A man sits at a desk holding a small replica house in his hand, upset at the sale of his property.
Broker Notes

Why did the Goodman share price suffer a sell-off in June?

June was a difficult month for many ASX shares, including Goodman.

Read more »

A little boy surrounded by green grass and trees looks up at the sky, waiting for rain or sunshine.
Bank Shares

Could the CBA share price turn over a new leaf in July?

Here's what brokers are thinking about the big four ASX bank.

Read more »

Happy woman looking through two doughnuts like binoculars
Technology Shares

Should investors zero in on the Xero share price in July?

Is this ASX tech share now too cheap to ignore?

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers are feeling positive about these ASX shares...

Read more »